{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:23:50Z","timestamp":1761863030358},"reference-count":5,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.lpm.2011.05.004","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T10:14:55Z","timestamp":1308996895000},"page":"784","source":"Crossref","is-referenced-by-count":2,"title":["Correspondance \u00e0 propos de l\u2019article \u00ab\u00a0Mortalit\u00e9 attribuable au benfluorex (Mediator\u00ae)\u00a0\u00bb"],"prefix":"10.1016","volume":"40","author":[{"given":"R\u00e9my","family":"Boussageon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2011.05.004_bib0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.lpm.2011.02.019","article-title":"Benfluorex (Mediator\u00ae), notre vigilance en question","volume":"40","author":"Frachon","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2011.05.004_bib0010","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.lpm.2011.03.001","article-title":"Mortalit\u00e9 attribuable au benfluorex (Mediator)","volume":"40","author":"Hill","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2011.05.004_bib0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.05.004_bib0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2337\/diacare.29.03.06.dc05-1439","article-title":"Efficacy of benfluorex in combination with sulfonylurea in type 2\u00a0diabetes patients","volume":"29","author":"Moulin","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lpm.2011.05.004_bib0025","doi-asserted-by":"crossref","unstructured":"Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, et al. Comparative effectiveness and safety of medications for Type 2\u00a0diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011 [Epub ahead of print].","DOI":"10.7326\/0003-4819-154-9-201105030-00336"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T08:31:40Z","timestamp":1560328300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":5,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0755498211002569"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.05.004","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}